Frequency Therapeutics   Report issue

For profit Phase 2
Founded: Woburn MA United States (2015)

Organization Overview

First Clinical Trial
2017
NCT03300687
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Frequency Therapeutics